Technology News and Research

RSS

Research provides better understanding of drugs used to treat, prevent cardiovascular disease

Using chemical labeling and mass spectrometry-based techniques, Mark Chance, PhD, director of the Case Western Reserve University School of Medicine Center for Proteomics and Bioinformatics and professor of physiology and biophysics; Sayan Gupta, PhD, instructor at the Case Center for Proteomics and Bioinformatics; and a research team from the University of Oxford, for the first time, were able to take a high resolution picture of the open state of a K+ channel, allowing them to comparatively analyze gating mechanisms important to heart function and nerve signaling - in addition these techniques have already permitted Case Western investigators to gain a deeper understanding of G-protein coupled receptors.

14 Jul 2010

Maven Semantic announces updates to database of Toxicology researchers

Maven Semantic announces updates to their Toxicology database.

14 Jul 2010

BioInvent reports net revenues of SEK 63.1M for January - June 2010 period

BioInvent reached an important milestone when the results of a phase II trial of TB-402 following orthopaedic surgery, were reported in May. The data showed that TB-402 is statistically better at preventing thrombosis than enoxaparin, the current standard treatment. Supported by these good results, BioInvent and the company's partner, ThromboGenics, will now prioritise securing a development partner for the programme to ensure that the necessary resources is in place to take the product candidate to the market.

14 Jul 2010

Maven Semantic releases updates to Biotechnology research database

Maven Semantic (http://www.mavensemantic.com) announces updates to their Biotechnology research database.

14 Jul 2010

ZyGEM launches new microbial fingerprinting diagnostic technology

ZyGEM Corp. Ltd., has introduced its new microbial fingerprinting diagnostic technology that is expected to dramatically reduce the complexity and time needed to identify unknown infectious agents in mixed population samples. The approach is designed to run on the company's new MicroLab platform and has the potential to accurately identify up to 30 types of microbes simultaneously from a single sample in less than an hour.

14 Jul 2010

Media outlets focus on audiences towards Alzheimer's disease: Intellect Neurosciences

Intellect Neurosciences, Inc., a biopharmaceutical company engaged in the discovery and development of disease-modifying therapeutic agents for the treatment and prevention of Alzheimer's disease, today announced that it is pleased with the recent press coverage the Company and Dr. Daniel G. Chain, Ph.D., the Company's Chairman and Chief Executive Officer, recently has received.

14 Jul 2010

WL Ross and Mac Crawford announce joint venture to co-invest in and restructure healthcare companies

Wilbur L. Ross, Jr., CEO of WL Ross & Co. LLC, and Edwin "Mac" Crawford announced today a joint venture, Crawford-Ross, to co-invest in and restructure healthcare companies. Mr. Ross said, "We are prepared to invest more than $1 billion to support Mac and his team as we jointly build a major position in healthcare."

14 Jul 2010

Verizon Health Information Exchange to be available soon to share patient information

One of the biggest obstacles to sharing patient information electronically is that health care systems and providers use a wide range of incompatible IT platforms and software to create and store data in various formats. A new service – the Verizon Health Information Exchange – will soon be available via the "cloud" to address this challenge.

14 Jul 2010

Medsphere Systems voices support for meaningful use criteria to improve patient care

Medsphere Systems Corporation, the leading provider of open-source healthcare enterprise solutions, today voiced support for the official "meaningful use" requirements released by the Department of Health and Human Services' Office of the National Coordinator for Health IT. These recently announced requirements will be used to determine hospitals' eligibility for millions in American Recovery and Reinvestment Act stimulus funds associated with deploying health IT solutions to improve patient care.

14 Jul 2010

Telecare management intervention improves pain, depression in cancer patients

Cancer patients receiving care in geographically dispersed urban and rural oncology practices who participated in a program that included telephone-based care management and home-based automated symptom monitoring had greater improvement in pain and depression compared to patients who received usual care, according to a study in the July 14 issue of JAMA.

14 Jul 2010

PCMA issues statement on release of 'meaningful use' final rules in HITECH Act

Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt issued the following statement on the release of today's "meaningful use" final rules in the Health Information Technology for Economic and Clinical Health (HITECH) Act:

14 Jul 2010

P2i acquires UK-based Surface Innovations

P2i Limited, the world leader in liquid repellent nano-coating technology, has acquired 100 per cent of the share capital of Surface Innovations Ltd, a UK-based technology company with a wide range of functional nano-coating patents.

14 Jul 2010

Syngenta signs long-term business agreement with Bayer CropScience

Syngenta and Bayer CropScience have entered into a long-term business agreement relating to a key plant biotechnology trait. Under the agreement, Syngenta has granted Bayer CropScience a worldwide, non-exclusive license for use of VIPCOT insect control technology in cotton.

14 Jul 2010

Research provides understanding of EGME's effects on metabolism

Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Ethylene Glycol Monomethyl Ether-Induced Toxicity is Mediated through the Inhibition of Flavoprotein Dehydrogenase Enzyme Family", in the journal Toxicological Sciences on July 8, 2010. The paper was co-authored by Dr. Makoto Takei and colleagues at Daiichi-Sankyo in collaboration with Metabolon scientists.

14 Jul 2010

IAS announces recipients of CNIHR grants

The International AIDS Society today announced the recipients of its first joint research grant programme, Creative and Novel Ideas in HIV Research. CNIHR grants, funded in partnership with the U.S. National Institutes of Health and the NIH-supported Centers for AIDS Research are designed to promote innovative research and new ideas from early stage investigators whose primary focus has previously been in fields of scientific inquiry other than HIV/ AIDS.

14 Jul 2010

Highlights of AAPM 52nd meeting

The 52nd meeting of the American Association of Physicists in Medicine (AAPM) convenes from July 18 - 22, 2010 in Philadelphia, PA.

14 Jul 2010

Silence Therapeutics extends ongoing research, development collaboration with AstraZeneca

Silence Therapeutics plc is pleased to announce a one-year extension of its ongoing research and development collaboration with AstraZeneca. Under the terms of the agreement, which has progressed well since being signed in July 2007, Silence and AstraZeneca are jointly collaborating in the identification and optimization of five novel siRNA therapeutic molecules addressing respiratory and oncology indications.

14 Jul 2010

Improved delivery methods needed to advance gene therapy strategies for prostate cancer: Review

Improved delivery methods and better testing systems are needed to advance promising gene therapy strategies for treating prostate cancer, according to a series of review articles in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc.

14 Jul 2010

MTBC welcomes final rule on meaningful use of EHR

MTBC, a unique healthcare IT company, welcomed today's release by the U.S. Department of Health and Human Services of the final rule on what constitutes "meaningful use" of an Electronic Health Record.

14 Jul 2010

Skin cell samples may help discover factors behind Parkinson's disease

Researchers are applying new stem cell technology to use skin samples to grow the brain cells thought to be responsible for the onset of Parkinson's disease

14 Jul 2010